Further analysis of multiple tumor tissue sections indicated that tumors from DC-iMB-treated animals presented a significant increase in CD4+ (2.2–4.3-fold, p < 0.005) and CD8+ T cells (4.3–10.9-fold, p < 0.005) compared to the other groups (Fig. 8d-e). This evidence concerns the gene CD4 and neoplasm.